Advertisement
Free, independent economic & markets data — verified from official sources (World Bank · IMF · OECD · NRB).
NepseTradingENनेपाली
Myanmar · Health expenditure

Myanmar Health expenditure

The World Bank — World Development Indicators (CC BY 4.0) · updated 2023-12-31

Latest · 20234.46%
Previous · 20224.49%
Highest · 20215.54%
Lowest · 20111.95%

Myanmar's health expenditure stands at 4.46% as of 2023-12-31, down from 4.49% in 2022. Historical data runs from 2000 to 2023 (24 observations).

Recent trend

In 2023, Myanmar's health expenditure was 4.46%, down from 4.49% in 2022.

In 2022, Myanmar's health expenditure was 4.49%, down from 5.54% in 2021.

In 2021, Myanmar's health expenditure was 5.54%, up from 4.28% in 2020.

In 2020, Myanmar's health expenditure was 4.28%, up from 3.81% in 2019.

In 2019, Myanmar's health expenditure was 3.81%, down from 4.54% in 2018.

Myanmar Health expenditure — historical data

YearValueChange
20234.46%-0.0341%
20224.49%-1.04%
20215.54%+1.26%
20204.28%+0.4636%
20193.81%-0.7207%
20184.54%-0.157%
20174.69%-0.0701%
20164.76%-0.4349%
20155.2%+1.05%
20144.15%+1.04%
20133.11%+0.6751%
20122.44%+0.4853%
20111.95%-0.0172%
20101.97%-0.2049%
20092.17%+0.0511%
20082.12%+0.0857%
20072.04%-0.2295%
20062.27%-0.0791%
20052.34%+0.0122%
20042.33%-0.0634%
20032.4%-0.1985%
20022.59%+0.4324%
20012.16%+0.1543%
20002.01%

The World Bank — World Development Indicators (CC BY 4.0) · Download this series as CSV — free, attribution required (CC BY 4.0).

More Myanmar data

Frequently asked questions

What is Myanmar's health expenditure?

Myanmar's health expenditure is 4.46% as of 2023-12-31, compared with 4.49% in 2022. The World Bank — World Development Indicators (CC BY 4.0)

What was the highest health expenditure in Myanmar?

The highest recorded value is 5.54% (2021); the lowest is 1.95% (2011), across data from 2000 to 2023.

Where does this data come from?

The World Bank — World Development Indicators (CC BY 4.0) Figures are republished with attribution and updated as the source releases new observations.